UAE Nucleic Acid Therapeutics Cdmo Market Size & Outlook
UAE nucleic acid therapeutics cdmo market, 2018-2030 (US$M)
Related Markets
UAE nucleic acid therapeutics cdmo market highlights
- The UAE nucleic acid therapeutics cdmo market generated a revenue of USD 70.9 million in 2023 and is expected to reach USD 155.5 million by 2030.
- The UAE market is expected to grow at a CAGR of 11.9% from 2024 to 2030.
- In terms of segment, rna-based therapies was the largest revenue generating type in 2023.
- Gene Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Nucleic acid therapeutics cdmo market data book summary
| Market revenue in 2023 | USD 70.9 million |
| Market revenue in 2030 | USD 155.5 million |
| Growth rate | 11.9% (CAGR from 2023 to 2030) |
| Largest segment | Rna-based therapies |
| Fastest growing segment | Gene Therapy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Therapy, RNA-based Therapies |
| Key market players worldwide | Catalent Inc, Thermo Fisher Scientific Inc, Lonza Group Ltd, FUJIFILM Holdings Corp, Charles River Laboratories International Inc, Eurofins Scientific SE, PerkinElmer, Oxford Biomedical Research, Danaher Corp |
Other key industry trends
- In terms of revenue, UAE accounted for 0.5% of the global nucleic acid therapeutics cdmo market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa nucleic acid therapeutics cdmo market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 352.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nucleic Acid Therapeutics CDMO Market Scope
Nucleic Acid Therapeutics CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE nucleic acid therapeutics cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleic acid therapeutics cdmo market will help companies and investors design strategic landscapes.
Rna-based therapies was the largest segment with a revenue share of 65.59% in 2023. Horizon Databook has segmented the UAE nucleic acid therapeutics cdmo market based on gene therapy, rna-based therapies covering the revenue growth of each sub-segment from 2018 to 2030.
The market for nucleic acid therapeutics CDMO in UAE is driven by increasing demand for advanced and personalized therapies, growing investment for various studies, and increasing emphasis on treating a wide range of genetic & chronic diseases.
In addition, commercial expansion strategy and delivering a top-quality sale & support experience to researchers and industry players have contributed to the market growth. For instance, in April 2023, Orbital Therapeutics raised USD 270 million in a Series A round led by ARCH Venture Partners to advance its programmable RNA therapeutics portfolio.
The initial investors of the Series A round were a16z Bio + Health and Newpath Partners. The company’s new investors are Abu Dhabi Growth Fund, Red mile Group, Invus, EXOR, Moore Strategic Ventures, iGlobe Platinum Fund Group, & Casdin Capital.
Reasons to subscribe to UAE nucleic acid therapeutics cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE nucleic acid therapeutics cdmo market databook
-
Our clientele includes a mix of nucleic acid therapeutics cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE nucleic acid therapeutics cdmo market , including forecasts for subscribers. This country databook contains high-level insights into UAE nucleic acid therapeutics cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE nucleic acid therapeutics cdmo market size, by type, 2018-2030 (US$M)
UAE Nucleic Acid Therapeutics CDMO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
